Pharmacotherapy in pediatric critical Illness: A prospective observational study

Pediatric Drugs

Volumn 11, Issue 5, 2009, Pages 323-331

  McDonnell, Conor ^a,b   Hum, Stanley ^a   Frndova, Helena ^a,b   Parshuram, Christopher S ^a,b,c,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFUROXIME; CHLORAL HYDRATE; CLOBAZAM; DEXAMETHASONE; DOMPERIDONE; ERYTHROMYCIN; FENTANYL; FUROSEMIDE; GENTAMICIN; HYDROCORTISONE; LORAZEPAM; MEROPENEM; METHYLPREDNISOLONE; MORPHINE; NYSTATIN; OMEPRAZOLE; PHENOBARBITAL; POTASSIUM; RANITIDINE; SALBUTAMOL; VANCOMYCIN;

ARTICLE; CHILD; COHORT ANALYSIS; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG UTILIZATION; EMERGENCY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 70349554300     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11310670-000000000-00000     Document Type: Article

References (40)

1. Tobias JD. Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005 Aug; 34 (8): 636-645
2. Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest 2006 Nov; 116 (11): 2837-2842
3. Giacoia GP, Birenbaum DL, Sachs HC, et al. The newborn drug development initiative. Pediatrics 2006 Mar; 117 (3 Pt 2): S1-S8
4. Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002 Jan 16; 287 (3): 345-355
5. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003 Feb 20; 348 (8): 683-693
6. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. ASAIO J 2005 Jan-Feb; 51 (1): 4-10
7. de Mos N, van Litsenburg RR, McCrindle B, et al. Pediatric in-intensive-care-unit cardiac arrest: incidence, survival, and predictive factors. Crit Care Med 2006 Apr; 34 (4): 1209-1215
8. Bordun LA, Butt W. Drug errors in intensive care. J Paediatr Child Health 1992 Aug; 28 (4): 309-311
9. Darchy B, Le Miere E, Figueredo B, et al. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 1999 Jan 11; 159 (1): 71-78
10. Boucher BA, Kuhl DA, Coffey BC, et al. Drug use in a trauma intensive-care unit. Am J Hosp Pharm 1990 Apr; 47 (4): 805-810
11. Buchanan N, Cane RD. Drug utilization in a general intensive care unit. Intensive Care Med 1978 Apr; 4 (2): 75-77
12. Farina ML, Levati A, Tognoni G. A multicenter study of ICU drug utilization. Intensive Care Med 1981 Apr; 7 (3): 125-131
13. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285 (16): 2114-2120
14. Aranda JV, Clarkson S, Collinge JM. Changing pattern of drug utilization in a neonatal intensive care unit. Am J Perinatol 1983 Oct; 1 (1): 28-30
15. Gavrilov V, Lifshitz M, Levy J, et al. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2000 Aug; 2 (8): 595-597
16. Bajcetic M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol 2005 Nov; 61 (10): 775-779
17. Manor-Shulman O, Beyene J, Frndova H, et al. Quantifying the volume of documented clinical information in critical illness. J Crit Care 2008 Jun; 23 (2): 245-250
18. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996 May; 24 (5): 743-752
19. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003 Jul 19; 362 (9379): 192-197
20. Farias JA, Frutos F, Esteban A, et al. What is the daily practice of mechanical ventilation in pediatric intensive care units? A multicenter study. Intensive Care Med 2004 May; 30 (5): 918-925
21. Flori HR, Glidden DV, Rutherford GW, et al. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 2005 May 1; 171 (9): 995-1001
22. Goldstein SL, Somers MJ, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005 Feb; 67 (2): 653-658
23. Anand KJ, Aranda JV, Berde CB, et al. Summary proceedings from the neonatal pain-control group. Pediatrics 2006 Mar; 117 (3 Pt 2): S9-S22
24. Tobias JD, Rasmussen GE. Pain management and sedation in the pediatric intensive care unit. Pediatr Clin North Am 1994 Dec; 41 (6): 1269-1292
25. Deshmukh CT, Rane SA, Gurav MN. Hypomagnesaemia in paediatric population in an intensive care unit. J Postgrad Med 2000 Jul-Sep; 46 (3): 179-180
26. Cook D, Crowther MA, Douketis J. Thromboprophylaxis in medical-surgical intensive care unit patients. J Crit Care 2005 Dec; 20 (4): 320-323
27. Duncan H, Hutchison J, Parshuram CS. The pediatric early warning system score: a severity of illness score to predict urgent medical need in hospitalized children. J Crit Care 2006 Sep; 21 (3): 271-278
28. Leteurtre S, Duhamel A, Grandbastien B, et al. Paediatric logistic organ dysfunction (PELOD) score. Lancet 2006 Mar 18; 367 (9514): 897; author reply 900-902
29. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003 Sep 18; 349 (12): 1157-1167
30. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I). Clin Pharmacokinet 1988 Apr; 14 (4): 189-216
31. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005 Aug; 33 (8): 1694-1700
32. Sharek PJ, Classen D. The incidence of adverse events and medical error in pediatrics. Pediatr Clin North Am 2006 Dec; 53 (6): 1067-1077
33. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999 Jul 21; 282 (3): 267-270
34. Wilson GN, Moore KA. Multiple-order intravenous drug management system in a medical/surgical intensive care unit: opportunities and challenges for pharmacy practice. ASHP Midyear Clinical Meeting 1990; 25: 261d
35. Parshuram CS, Ng GY, Ho TK, et al. Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med 2003 Oct; 31 (10): 2483-2487
36. Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med 2005 Mar; 33 (3): 533-540
37. Weinger MB. Drug wastage contributes significantly to the cost of routine anesthesia care. J Clin Anesth 2001 Nov; 13 (7): 491-497
38. Parshuram CS. Pharmacotherapeutic friendly fire in the intensive care unit: high stakes seeking high calibre. Crit Care 2008; 12 (2): 137-138
39. Lopez Martinez R, Cabanas Poy MJ, Oliveras Arenas M, et al. Drug use in a neonatal ICU: a prospective study. Farm Hosp 2005 Jan-Feb; 29 (1): 26-29
40. Uppal N, Dupuis L, Parshuram CS. Paediatric labelling in drug monographs contained in the Canadian Compendium of Pharmaceuticals and Specialties. Pediatr Drugs 2008 May; 10 (3): 193-197